Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease
NCT00220272
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
183
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
SR57667B
Sponsor
Sanofi